Optilume BPH

United States · 23 Employees
The Optilume® drug-coated balloon technology provides a minimally invasive treatment option for men suffering from urinary tract conditions like urethral strictures and benign prostatic hyperplasia (BPH). BPH affects 70% of men 60-69 years of age and 80% of those 70 years of age or older. The drug-coated balloon technology creates a paradigm change from the methods currently used by urologists to treat these conditions.

概述

国家 United States
成立时间 2015
总部 2495 Xenium Lane N, Plymouth, MN 55441, US
电话号码 +1 763-285-7496
网站 http://www.urotronic.com
LinkedIn http://www.linkedin.com/company/optilumebph
Twitter https://twitter.com/urotronic
Facebook
员工数 23
行业 medical devices,
简介 The Optilume® drug-coated balloon technology provides a minimally invasive treatment option for men suffering from urinary tract conditions like urethral strictures and benign prostatic hyperplasia (BPH). BPH affects 70% of men 60-69 years of age and 80% of those 70 years of age or older. The drug-coated balloon technology creates a paradigm change from the methods currently used by urologists to treat these conditions.

技术

Microsoft Office 365

Other

Outlook

Email Providers

Remote

Other

常见问题

Optilume BPH 在哪里?

Optilume BPH 的总部位于 2495 Xenium Lane N, Plymouth, MN 55441, US

Optilume BPH 的电话号码是多少?

Optilume BPH 的电话号码是 +1 763-285-7496

Optilume BPH 的官方网站是什么?

Optilume BPH 的公司官方网站是 http://www.urotronic.com

Optilume BPH 是做什么的?

Optilume BPH 的业务有哪些?

medical device,engineering,start up,urology,drug coated balloon,stricture

Optilume BPH 的年收入是多少?

Optilume BPH 的收入是 3000000美元

Optilume BPH 有多少员工?

Optilume BPH 有 23 名员工

Optilume BPH 属于哪个行业?

Optilume BPH 从事以下行业: medical devices

Optilume BPH 使用什么技术?

Optilume BPH 使用的一些流行技术包括: Microsoft Office 365,Outlook,Remote

如何联系 Optilume BPH?

Optilume BPH 联系信息: 电话号码:+1 763-285-7496, 网站:http://www.urotronic.com, 邮箱:ree***@***.com

Optilume BPH 的社交媒体链接是什么?

Optilume BPH 领英:http://www.linkedin.com/company/optilumebph,fackbook:,twitte:https://twitter.com/urotronic

Optilume BPH 是一家上市公司吗?

不是

Optilume BPH 的最后一轮融资是什么时候?

Optilume BPH在2020-10-09T00:00:00.000+00:00结束了最后一轮融资,金额达20M$。

谁投资 Optilume BPH?

Optilume BPH 有 3 家投资者,包括 Laborie Medical Technologies Inc, Mayo Clinic, Hillhouse Capital Group of China、CDBI Partners, Legend Capital、Legend Capital。

管理层

Mackenzie Ree

Manager, Analytical Chemistry

Brad Andersen

VP Operations and Quality

Ian Schorn

Vice President Clinical Affairs

Jill Moland

Clinical Program Director

Harrison Malinoff

Vice President Operations

员工

Tim O'Neill

Clinical Consultant

Joshua Adamek

Analytical Chemist

Billy Yang

Research And Development Technician

外贸获客 查找关键决策人

10亿+海关交易数据,1.2亿企业数据,2亿+企业联系人数据,1000千万真实采购商。覆盖200+个国家及地区,95%外贸重点拓展市场,可根据行业、经营范围等多方位挖掘目标客户。
免费试用

Top-ranked on G2 Crowd

全球B2B企业库 海关贸易数据 展会采购数据

工作更少,成就更大,销售更聪明

查找更多 B2B 联系人,丰富并验证记录
Email Address

全球B2B企业库

海关贸易数据

展会采购数据

Top-ranked on G2 Crowd

OR
Sign Up with Google